# OnCo record paper-fresco-2-lancet-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-fresco-2-lancet-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-fresco-2-lancet-2023" ;
  schema:name "Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study"@en ;
  schema:description "Published report from the FRESCO-2 trial registered as NCT04322539, in The Lancet (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-fresco-2-lancet-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(23)00772-9>, <https://pubmed.ncbi.nlm.nih.gov/37331369/>, <https://europepmc.org/article/MED/37331369>, <https://clinicaltrials.gov/study/NCT04322539> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(23)00772-9> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Dasari A, Lonardi S, Garcia-Carbonero R, et al." ;
  onco:trials <https://onco.cc/trials/fresco-2/> ;
  onco:journals <https://onco.cc/journals/lancet/> .